Net Income

Calero’s top CRN rating highlights a major shift, demanding channel partners become strategic advisors for managing complex tech spend.

At its 90th anniversary, the Ford Foundation appoints Jason W. Ingle, Henry Ford's great-great-grandson, signaling a new chapter blending legacy with impact investing.

New research reveals a daily serving of peanut butter can improve muscle power in older adults, offering an affordable way to maintain independence.

Alkira launches its Connect Partner Program, betting on a service-led channel to solve enterprise AI and cloud networking challenges.

Jawhara Jewellers ditches bank loans for an $80M gold-for-gold lease, signaling a major shift in how the industry handles price volatility and risk.

Unifi launches Luxel, a new yarn blending linen's feel with performance tech and circular recycling, aiming to redefine sustainable fashion and home goods.

A new partnership brings lab-grade chemical analysis out of the lab, combining compact instruments for high-sensitivity detection at the point of need.

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

Despite massive AI spending, a new report shows only a third of projects are profitable, pointing to hidden costs in data storage and cloud security.

After a strong Q4, Amprius launches a strategic roadshow to pitch its high-energy silicon anode batteries to investors and key aerospace and defense players.

As co-founder Matthew Bush takes the helm, Hirebotics doubles down on its mission to empower fabricators with user-friendly robots amid a historic labor crisis.

A new partnership gives thousands of young athletes in Las Vegas free recovery tech while a unique manufacturing model boosts the local economy.

The asset manager is one of only three firms to secure top-ten spots in Barron's rankings for 1, 5, and 10-year performance. We dissect their success.

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

How one bank’s focus on employee-led volunteerism and financial inclusion is redefining success and earning national recognition in the equipment finance sector.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

The neurohealth firm surpassed revenue estimates and hit positive cash flow, but a dynamic competitive landscape and CEO transition loom ahead of its earnings call.

As Akebia heads to a major conference, investors watch its Vafseo launch, new rare disease pipeline, and path to profitability. Here's what's at stake.

A novel drug delivery system could revolutionize Alzheimer's treatment, and Acumen Pharmaceuticals is leading the charge with its targeted therapy.

As Uni-Fuels blankets Thailand with bunkering services, the move highlights the nation's rising maritime importance and the intense battle for market share.